Skip to main content

Therapeutics Startups

Updated October 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,723 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,723
Total Funding
$1.8B
Avg Funding
$70.9M
Global Reach
5
countries

Top Cities for Therapeutics

Oak Brook
Longmont
Morrisville
Boston
Aberdeen
Bristol

Recently Funded Companies

Export
Oak Brook, United States

Hopemark Health is a psychiatric clinic offering mental health care, ketamine therapy, and genetic testing services.

$1.5M raised
May 2026

Founder Contacts

41,000+ verified contacts

Longmont, United States

Beryl is developing a patented first-in-class small molecule to increase peak bone mass and cure poor bone mineral density.

$250K raised
May 2023

Founder Contacts

41,000+ verified contacts

Morrisville, United States

Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.

$35.0M raised
May 2022

Founder Contacts

41,000+ verified contacts

Boston, United States

PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to bring more cures to patients

May 2022

Founder Contacts

41,000+ verified contacts

Aberdeen, United Kingdom

Elasmogen is a precision biologics drug discovery company that develops soloMERs.

$9.9M raised
May 2022

Founder Contacts

41,000+ verified contacts

Bristol, United Kingdom

Halo Therapeutics develops antivirals to prevent users from sickness.

$1.9M raised
May 2023

Founder Contacts

41,000+ verified contacts

West Lafayette, United States

MorphImmune is a preclinical biotechnology company that targets small-molecule therapeutics.

$15.0M raised
May 2023

Founder Contacts

41,000+ verified contacts

La Jolla, United States

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

$100.0M raised
May 2023

Founder Contacts

41,000+ verified contacts

Chicago, United States

Pathos is a biotechnology company that leverages AI to accelerate oncology drug development.

$365.0M raised
May 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.

$177.0M raised
May 2025

Founder Contacts

41,000+ verified contacts

Solana Beach, United States

ClearPath Vascular is a healthcare company that offers technologies that can be used in neuro and peripheral vascular procedures.

$1.0M raised
May 2025

Founder Contacts

41,000+ verified contacts

Malvern, United States

Uniquity Bio is a clinical-stage drug development company focused on advancing scientific innovation and delivering novel medicines.

$300.0M raised
May 2024

Founder Contacts

41,000+ verified contacts

Boston, United States

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

$40.0M raised
May 2023

Founder Contacts

41,000+ verified contacts

Calgary, Canada

XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease

$5.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Bainbridge Island, United States

Solius is a new technology to help vitamin D deficient Canadian for human health.

$3.5M raised
May 2026

Founder Contacts

41,000+ verified contacts

Madrid, Spain

Biohope is dedicated to the development of diagnostic and therapeutic solutions for organ transplantation.

May 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.

$122.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

New Haven, United States

CapeHaven is a biotech venture builder that focuses on developing therapeutics into financeable businesses.

$10.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.

$10.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

Kyiv, Ukraine

pleso therapy is an anxiety-free managed mental health marketplace for 1:1 sessions with verified therapists

$1.2M raised
May 2025

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.

$712K raised
May 2024

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Violet Therapeutics is a pre-clinical stage company leveraging first-in-class platforms to identify, map, and mine the cellular connectome.

$4.8M raised
May 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Swing Therapeutics provides digital therapeutics for people with chronic conditions.

May 2026

Founder Contacts

41,000+ verified contacts

Duxbury, United States

Granata Bio is a biotechnology company developing therapeutic solutions to address infertility and improve women's reproductive health.

May 2025

Founder Contacts

41,000+ verified contacts

New York, United States

Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders.

$570.0M raised
May 2025

Founder Contacts

41,000+ verified contacts

Showing 576 to 600 of 1,723 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,723 therapeutics companies tracked in the VCBacked database.

Average Funding
$70.9M
Total Funding Tracked
$1.8B
Countries Represented
5

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.Boston
3 companies$217.0M
2.Cambridge
2 companies$126.8M
3.Oak Brook
1 companies$1.5M
4.Longmont
1 companies$250K
5.Morrisville
1 companies$35.0M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked